Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Election Fraction

被引:28
|
作者
Regan, Jessica A. [1 ]
Kitzman, Dalane W. [2 ]
Leifer, Eric S. [3 ]
Kraus, William E. [1 ,7 ]
Fleg, Jerome L. [3 ]
Forman, Daniel E. [4 ,5 ]
Whellan, David J. [6 ]
Wojdyla, Daniel [7 ]
Parikh, Kishan [1 ,7 ]
O'Connor, Christopher M. [8 ]
Mentz, Robert J. [1 ,7 ]
机构
[1] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[2] Wake Forest Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA
[3] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[6] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA
[7] Duke Clin Res Inst, Durham, NC USA
[8] Inova Heart & Vasc Inst, Falls Church, VA USA
基金
美国国家卫生研究院;
关键词
age; body mass index; comorbidities; depression; heart failure with reduced ejection fraction; HF-ACTION; NONCARDIAC COMORBIDITIES; EJECTION FRACTION; OBESITY PARADOX; CO-MORBIDITIES; OLDER-ADULTS; DEPRESSION; MORTALITY; RISK; MULTIMORBIDITY;
D O I
10.1016/j.jchf.2019.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to determine whether age modifies the impact of key comorbidities on clinical outcomes for patients with heart failure with reduced ejection fraction (HFrEF). BACKGROUND Comorbidities impact outcomes in HFrEF. However, the effect of age on the impact of comorbidities on prognosis is not clearly understood. METHODS Cox proportional hazards models were used assessed interactions between age and comorbidities on the primary composite endpoint (all-cause mortality or hospitalization) and secondary endpoints in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) multicenter trial of 2,331 patients with HFrEF. RESULTS Age did not significantly modify the effect of any comorbidity on the primary endpoint. However, age significantly modified the effect of body mass index (BMI) on all-cause mortality (interaction p = 0.02). Among patients >= 70 years of age, there was a U-shaped relationship between BMI and 1-year mortality, where BMI of 20 kg/m(2) corresponded to 17.6%; a BMI of 30 kg/m(2) corresponded to 7.0%; and a BMI of 40 kg/m(2) corresponded to 11%. For patients <60 years of age, mortality increased nonsignificantly from 3.2% to 3.7% with increasing BMI. Age also modified the effect of depressive symptoms on alt-cause mortality (interaction p = 0.03). Among patients >= 70 years of age, a 1-year mortality rate significantly increased from 7.8% for a Beck Depression Inventory (BOO score of 5% to 15.6% for BIN of 20. For patients <60 years of age, mortality was nonsignificantly related to BDI. Cumulative comorbidity scores were stronger predictors than age for mortality/hospitalization. CONCLUSIONS hi chronic HFrEF, age markedly altered the impact of BMI and depressive symptoms on all-cause mortality, with much higher risk in older patients, but was not as strong a predictor of mortality/hospitalizations as cumulative comorbidity score. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:1056 / 1065
页数:10
相关论文
共 50 条
  • [21] The Impact of Extra Cardiac Comorbidities on Pressure Volume Relations in Heart Failure and Preserved Ejection Fraction
    Abramov, Dmitry
    He, Kun-Lun
    Wang, Jie
    Burkhoff, Daniel
    Maurer, Mathew S.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (07) : 547 - 555
  • [22] Impact of Cardiorespiratory Fitness on the Obesity Paradox in Heart Failure with Reduced Ejection Fraction
    Moreira, Rita Ilhao
    Silva, Tiago Pereira
    Goncalves, Antonio Valentim
    Feliciano, Joana
    Rio, Pedro
    Soares, Rui
    Ferreira, Rui Cruz
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 115 (04) : 639 - 645
  • [23] Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction
    Antonietta, Cicoira Maria
    Calvi, Emiliano
    Faggiano, Andrea
    Maffeis, Caterina
    Bosisio, Marco
    De Stefano, Marco
    Carugo, Stefano
    Faggiano, Pompilio
    CURRENT HEART FAILURE REPORTS, 2022, 19 (01) : 15 - 25
  • [24] Impact of comorbidities in heart failure
    Bauer, F.
    REVUE DE MEDECINE INTERNE, 2019, 40 : A37 - A39
  • [25] Comorbidities in heart failure with preserved ejection fraction
    Deichl, Andrea
    Wachter, Rolf
    Edelmann, Frank
    HERZ, 2022, 47 (04) : 301 - 307
  • [26] Cardiac Rehabilitation Outcomes IMPACT OF COMORBIDITIES AND AGE
    Listerman, Jennifer
    Bittner, Vera
    Sanderson, Bonnie K.
    Brown, Todd M.
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2011, 31 (06) : 342 - 348
  • [27] Heart failure with preserved ejection fraction: Squaring the circle between comorbidities and cardiovascular abnormalities
    Marra, Alberto Maria
    Bencivenga, Leonardo
    D'Assante, Roberta
    Rengo, Giuseppe
    Cittadini, Antonio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 99 : 1 - 6
  • [28] A Bayesian Study of the Dynamic Effect of Comorbidities on Hospital Outcomes of Care for Congestive Heart Failure Patients
    Zikos, Dimitrios
    Zimeras, Stelios
    Ragina, Neli
    TECHNOLOGIES, 2019, 7 (03)
  • [29] Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction
    Bayoumi, Essraa
    Lam, Phillip H.
    Dooley, Daniel J.
    Singh, Steven
    Faselis, Charles
    Morgan, Charity J.
    Patel, Samir
    Sheriff, Helen M.
    Mohammed, Selma F.
    Palant, Carlos E.
    Pitt, Bertram
    Fonarow, Gregg C.
    Ahmed, Ali
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (01) : 71 - +
  • [30] Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
    Qamer, Syed Z.
    Malik, Awais
    Bayoumi, Essraa
    Lam, Phillip H.
    Singh, Steven
    Packer, Milton
    Kanonidis, Ioannis E.
    Morgan, Charity J.
    Abdelmawgoud, Ahmed
    Allman, Richard M.
    Fonarow, Gregg C.
    Ahmed, Ali
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (11) : 1311 - 1319